Covered by insurance in all 50 states, incl. Medicare Advantage day one
Back to Blog

Mood Stabilizers for Bipolar: Which One Protects Against What

Clinically reviewed by Daniel Montville, MD

Reviewed November 5, 2026 · Last updated November 5, 2026

Key Takeaways

  • Some mood stabilizers also treat acute episodes, but their long-term job is prevention: lowering the chance of the next manic or depressive episode.
  • Lithium has the strongest evidence for preventing mania and strong evidence for lowering suicide risk. A network meta-analysis of 33 trials recommends it as the first-line choice.
  • Lamotrigine is best for preventing depressive episodes but protects less against mania. Valproate prevented relapse less well than lithium in a head-to-head trial.
  • Stopping quickly is risky. After rapid discontinuation of lithium, a new episode arrived in a median of 3.5 months, compared with 10.6 months after a gradual taper.
  • Antidepressants need extra care in bipolar disorder. An expert task force advises using them in bipolar I only alongside a mood stabilizer.

If you’ve just been prescribed a mood stabilizer, you might worry it will flatten who you are. Or maybe you’ve felt steady for months and you’re wondering why you still need it. Both questions are fair, and you deserve straight answers about what these medications actually do.

Bipolar disorder moves in two directions, toward mania and toward depression, and over the long run mood stabilizers work mainly by lowering the chance of the next episode in either direction. They aren’t interchangeable. A lithium prevention meta-analysis found a clear protective effect against manic episodes but a less certain one against depressive episodes, and other drugs show the opposite pattern. Choosing well takes precision about which direction your episodes tend to go.

The established standard is lithium. A 33-trial network meta-analysis concluded it should remain the first-line choice for preventing relapse, given its effect on both manic and depressive episodes and the quality of evidence behind it. The results are real, and the science is well established.

But a first-line drug doesn’t fit every body or every pattern of episodes, and at Siggy we believe a medication plan should match how your illness actually behaves and keep checking in long after the first prescription.

That’s the idea behind matching treatment to predominant polarity, meaning the direction your episodes most often take. A predominant polarity review found that about half of people with bipolar disorder have a course dominated by either mania or depression, and that maintenance drugs differ widely in which direction they protect against. That difference is grounded in trial data on each medication, rather than in habit or preference.

What This Page Covers

What Does a Mood Stabilizer Actually Do?

Mood stabilizers are medications used to treat mood episodes in bipolar disorder and to prevent new ones, and this article focuses on prevention. The term is loosely defined. It always includes lithium and anticonvulsants like lamotrigine and valproate, and some antipsychotics are also used for prevention. For acute mania, a 68-trial network meta-analysis found lithium and valproate worked better than placebo, while lamotrigine didn’t.

The 33-trial network meta-analysis compared 17 treatments in 6,846 people. Most were better than placebo at preventing a new mood episode, but they differed in how well they worked, which episodes they prevented, and how easy they were to tolerate.

The goal is fewer episodes over months and years, which is why the benefit can be easy to miss when things are going well. If a medication ever leaves you feeling flat or unlike yourself, treat that as a side effect to report, rather than a price you have to pay.

Which Mood Stabilizer Protects Against What?

The three classic mood stabilizers each have a different strength.

Lithium is strongest against mania. In the lithium prevention meta-analysis, it cut the risk of a manic episode by about half compared with placebo, and it also outperformed lamotrigine at preventing manic and hypomanic episodes.

Lamotrigine is strongest against depression. In an 18-month placebo-controlled trial of people who had recently been manic or hypomanic, both lamotrigine and lithium prevented mood episodes, and lamotrigine was particularly effective at preventing depression.

Valproate prevents relapse, though less well than lithium. In the BALANCE relapse trial of 330 people with bipolar I disorder, 69% of those taking valproate alone needed new treatment for a mood episode within two years, compared with 59% on lithium alone.

Here’s a quick comparison of those findings.

Medication Strongest Evidence Key Caution
Lithium Preventing mania, lowering suicide risk Thyroid, kidney, and calcium effects
Lamotrigine Preventing depressive episodes Less protection against mania, rare serious rash
Valproate Preventing relapse, less than lithium High risk during pregnancy

The cautions in the table are covered in the side effects section below. The predominant polarity review measured these differences with a polarity index, which ranged from 0.4 for lamotrigine, the most depression-protective, to 12.1 for aripiprazole, the most mania-protective. The idea is still being tested, so it helps guide the choice rather than dictate it.

Why Is Lithium Still the First Choice?

Lithium has the deepest evidence base of any mood stabilizer, and it also has strong evidence for lowering suicide risk. A 48-trial suicide meta-analysis involving 6,674 people found that lithium reduced suicides compared with placebo, with an odds ratio of 0.13, and also reduced deaths from any cause. It tended to do better than the other active treatments it was compared with.

Lithium also held up against the alternatives. In BALANCE, lithium alone and lithium plus valproate both prevented relapse better than valproate alone. Adding valproate to lithium couldn’t be shown to beat lithium by itself.

The tradeoff is tolerability. In the network meta-analysis, lamotrigine was better tolerated than lithium, which is one reason prescribers weigh your history, health, and goals rather than defaulting to one drug. Our guides to lithium for bipolar disorder, Lamictal for bipolar disorder, and Depakote for bipolar disorder go deeper on each medication.

What Side Effects and Monitoring Should You Expect?

Lithium needs regular blood work. A Lancet lithium safety review covering 385 studies found it raised the odds of an underactive thyroid about sixfold and reduced the kidneys’ ability to concentrate urine. The absolute risk of serious kidney failure was small: 0.5% of patients needed dialysis or another kidney replacement therapy. Lithium also raised calcium levels, so the authors recommend checking calcium before and during treatment. People taking lithium gained more weight than those on placebo, though less than those taking olanzapine.

Valproate’s biggest concern is pregnancy. A BMJ pregnancy safety review, drawing mostly on data from women taking these drugs for epilepsy, found valproate is linked to elevated risks of major birth defects and neurodevelopmental problems in exposed children, while lamotrigine was relatively safe. If pregnancy is possible for you, this belongs in the conversation before a prescription is written.

Lamotrigine carries a boxed warning for serious, sometimes life-threatening skin rashes, including Stevens-Johnson syndrome. According to the Lamictal prescribing information, serious rashes occurred in about 0.08% to 0.3% of adults, nearly always within the first 2 to 8 weeks, and the risk rises if the dose is started or raised faster than recommended or if it’s combined with valproate. That’s why it’s started low and increased slowly, and why any new rash should go to your prescriber right away. Our Lamictal guide walks through the schedule.

What Happens If You Stop a Mood Stabilizer?

Feeling well can be a sign that the medication is working, which is exactly what makes stopping tempting. How you stop matters, though. In a lithium discontinuation study of 227 people who stopped long-term lithium, those who stopped rapidly had a new episode in a median of 3.5 months, compared with 10.6 months for those who tapered over two weeks or more.

If side effects or doubts are making you want to stop, that’s worth raising with your prescriber rather than handling on your own. A prescriber may be able to adjust the dose, the timing, or the medication itself.

Why Do Antidepressants Need Extra Care in Bipolar Disorder?

Antidepressants can push some people with bipolar disorder into hypomania, mania, or a mixed state. An international task force report found the evidence for antidepressants in bipolar disorder is weak and recommended that people with bipolar I take them only alongside a mood stabilizer. The task force also noted that SSRIs and bupropion may carry a lower risk of switching than older antidepressants and SNRIs.

That’s why your full mood history matters before anyone starts an antidepressant, including any past stretches of unusually high energy or mood. Our guide to bipolar depression vs depression explains how the two can look alike.

How Siggy Fits In

Siggy’s licensed prescribers diagnose and treat the full range of mental health conditions, including bipolar disorder. Managing bipolar disorder well usually means mood stabilizers and ongoing care from a prescriber who knows the condition.

Siggy can help from the front door. The anonymous intake asks for no name, email, or account, so you can describe your full mood history, including highs, without worrying how it sounds. A licensed prescriber reviews your full intake before anything is prescribed, and your downloadable summary gives any clinician a clear record to start from.

Siggy isn’t an emergency service. If you or someone you love is in a severe manic episode, losing touch with reality, or thinking about suicide, call 911 or call or text 988. This article is for education only and isn’t a substitute for personal medical advice. Don’t start, stop, or change a mood stabilizer without your prescriber. It reflects sources available as of October 2026.

Start Your Anonymous Intake

If you’re in crisis right now, call 911 or call or text 988 first. If you’ve been living with mood swings no one has fully explained, and you want your whole history on the record before the next step, start your anonymous intake. It’s free, there’s no name or email required, and a licensed prescriber reviews your intake before anything is prescribed. Your summary is yours to keep and share with whoever helps you next.

Mental healthcare should stay with you between appointments.

Siggy combines daily check-ins with clinician-supervised care so your treatment plan can respond to what is actually happening.

Start anonymously. A real doctor reviews every clinical decision. HIPAA-compliant.

Start Anonymous Intake

Frequently Asked Questions

What is the most common mood stabilizer for bipolar disorder?

Lithium is the most established mood stabilizer for bipolar disorder. A network meta-analysis of 33 trials recommended it as the first-line choice for preventing relapse because it protects against both manic and depressive episodes and has the strongest body of evidence.

Which mood stabilizer is best for bipolar depression?

Lamotrigine has the best evidence among mood stabilizers for preventing depressive episodes. In an 18-month placebo-controlled trial, it worked particularly well for preventing depression, while lithium did better at preventing mania.

Do mood stabilizers cause weight gain?

Some mood stabilizers can cause weight gain. In a large review, people taking lithium gained more weight than people taking placebo, though less than people taking the antipsychotic olanzapine.

Can you stop a mood stabilizer if you feel well?

Stopping a mood stabilizer raises the chance of a new episode, especially if you stop quickly. In a study of 227 people who stopped lithium, a new episode came in a median of 3.5 months after rapid discontinuation versus 10.6 months after a gradual taper of two weeks or more.

Why does lithium require blood tests?

Lithium requires blood tests because the right dose depends on your blood level and because it can affect your thyroid, kidneys, and calcium. In a major trial, lithium was dosed to a blood level of 0.4 to 1.0 mmol/L, and a large review recommends checking calcium before and during treatment.

Is valproate safe during pregnancy?

Valproate carries a high risk during pregnancy. A BMJ review, drawing mostly on data from women with epilepsy, found it is linked to elevated risks of major birth defects and neurodevelopmental problems in children exposed before birth, while lamotrigine was relatively safe.

Does Siggy prescribe mood stabilizers?

Yes. Siggy's licensed prescribers diagnose and treat the full range of mental health conditions, including bipolar disorder, and a prescriber can talk with you about whether a mood stabilizer fits. The anonymous intake also gives you a summary of your full mood history to keep and share with any clinician.

Sources

  1. Severus E, Taylor MJ, Sauer C, et al. Lithium for prevention of mood episodes in bipolar disorders: systematic review and meta-analysis. International Journal of Bipolar Disorders. 2014;2:15. doi:10.1186/s40345-014-0015-8
  2. Miura T, Noma H, Furukawa TA, et al. Comparative efficacy and tolerability of pharmacological treatments in the maintenance treatment of bipolar disorder: a systematic review and network meta-analysis. The Lancet Psychiatry. 2014;1(5):351-359. doi:10.1016/S2215-0366(14)70314-1
  3. Carvalho AF, Quevedo J, McIntyre RS, et al. Treatment implications of predominant polarity and the polarity index: a comprehensive review. International Journal of Neuropsychopharmacology. 2014;18(2):pyu079. doi:10.1093/ijnp/pyu079
  4. Bowden CL, Calabrese JR, Sachs G, et al. A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently manic or hypomanic patients with bipolar I disorder. Archives of General Psychiatry. 2003;60(4):392-400. doi:10.1001/archpsyc.60.4.392
  5. BALANCE investigators and collaborators; Geddes JR, Goodwin GM, Rendell J, et al. Lithium plus valproate combination therapy versus monotherapy for relapse prevention in bipolar I disorder (BALANCE): a randomised open-label trial. The Lancet. 2010;375(9712):385-395. doi:10.1016/S0140-6736(09)61828-6
  6. Cipriani A, Hawton K, Stockton S, Geddes JR. Lithium in the prevention of suicide in mood disorders: updated systematic review and meta-analysis. BMJ. 2013;346:f3646. doi:10.1136/bmj.f3646
  7. McKnight RF, Adida M, Budge K, et al. Lithium toxicity profile: a systematic review and meta-analysis. The Lancet. 2012;379(9817):721-728. doi:10.1016/S0140-6736(11)61516-X
  8. Hope OA, Harris KM. Management of epilepsy during pregnancy and lactation. BMJ. 2023;382:e074630. doi:10.1136/bmj-2022-074630
  9. Baldessarini RJ, Pinna M, Contu M, et al. Risk factors for early recurrence after discontinuing lithium in bipolar disorder. Bipolar Disorders. 2022;24(7):720-725. doi:10.1111/bdi.13206
  10. Pacchiarotti I, Bond DJ, Baldessarini RJ, et al. The International Society for Bipolar Disorders (ISBD) task force report on antidepressant use in bipolar disorders. American Journal of Psychiatry. 2013;170(11):1249-1262. doi:10.1176/appi.ajp.2013.13020185
  11. Cipriani A, Barbui C, Salanti G, et al. Comparative efficacy and acceptability of antimanic drugs in acute mania: a multiple-treatments meta-analysis. The Lancet. 2011;378(9799):1306-1315. doi:10.1016/S0140-6736(11)60873-8
  12. Lamictal (lamotrigine) prescribing information. DailyMed, U.S. National Library of Medicine. dailymed.nlm.nih.gov